Krishna Institute of Medical Sciences Ltd Q4 FY26 Results

Summary

Krishna Institute of Medical Sciences Limited reported a robust 35.3% year-on-year growth in total revenue to ₹1,084 crore for Q4 FY26, with full-year FY26 revenue reaching ₹3,931 crore, up 28.2% year-on-year. However, profitability saw a decline, with Q4 FY26 PAT at ₹33 crore compared to ₹106 crore in the prior year, and full-year PAT at ₹242 crore, down from ₹415 crore in FY25. The EBITDA margin for Q4 FY26 was 19.9%, a notable decrease from 25.3% in Q4 FY25. Operational highlights included strong growth in both IP and OP volumes for FY26, alongside significant clinical achievements in specialized medical procedures.

Key Highlights

1. 1

   Total revenue for Q4 FY26 reached ₹1,084 crore, marking a significant increase of 35.3% year-on-year and 8.1% quarter-on-quarter.

2. 2

   For the full financial year 2026, total revenue grew by 28.2% year-on-year to ₹3,931 crore.

3. 3

   EBITDA for Q4 FY26 stood at ₹216 crore, growing by 6.8% year-on-year, while the EBITDA margin was 19.9%, a decrease from 25.3% in Q4 FY25.

4. 4

   Profit after tax (PAT) for Q4 FY26 was ₹33 crore, a substantial decline from ₹106 crore in Q4 FY25 and ₹52 crore in Q3 FY26.

5. 5

   Full-year PAT for FY26 decreased to ₹242 crore from ₹415 crore in FY25, and consolidated EPS for FY26 saw a degrowth of 37.2% to ₹6.03.

6. 6

   Consolidated Inpatient (IP) volume grew by 15.4% and Outpatient (OP) volume by 25.4% on a year-on-year basis for FY26.

7. 7

   KIMS Secunderabad performed India's first smart Cochlear implant surgery on a 3-year-old child, highlighting clinical advancements during Q4 FY26.